Table 1. Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections in the Population of Qatar.
Disease Outcome* | Reinfection† | Primary Infection† | Odds Ratio (95% CI) |
---|---|---|---|
no. of persons with outcome/no. of persons with infection that was not severe, critical, or fatal | |||
Severe disease | 4/1300 | 158/6095 | 0.12 (0.03–0.31) |
Critical disease | 0/1300 | 28/6095 | 0.00 (0.00–0.64) |
Fatal disease | 0/1300 | 7/6095 | 0.00 (0.00–2.57) |
Severe, critical, or fatal disease | 4/1300 | 193/6095 | 0.10 (0.03–0.25) |
Severe disease, critical disease, and fatal disease were defined on the basis of the World Health Organization criteria for classifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection severity and coronavirus disease 2019 (Covid-19)–related death.
Reinfections were matched with up to five primary infections according to sex, 5-year age group, nationality, and calendar week of polymerase-chain-reaction testing. The final sample therefore includes persons with reinfection who were matched to five or fewer persons with primary infection.